期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
巴雷特食道的病理特点及诊断标准 被引量:3
1
作者 雷道年 《医师进修杂志》 北大核心 2003年第8期3-5,共3页
关键词 巴雷特食道 病理特点 诊断标准 巴雷特食道癌
下载PDF
Endoscopic Mucosal Resection 被引量:1
2
作者 A. H. Hlscher H. Schfer 《The Chinese-German Journal of Clinical Oncology》 CAS 2004年第4期223-225,共3页
Endoscopic mucosal resection is indicated in limited esophageal carcinomas with in?ltration of the mucosa. As submucosal cancer is combined with a rate of lymph node metastasis in up to 30% mucosectomy is not the proc... Endoscopic mucosal resection is indicated in limited esophageal carcinomas with in?ltration of the mucosa. As submucosal cancer is combined with a rate of lymph node metastasis in up to 30% mucosectomy is not the procedure of choice. The main techniques of endoscopic mucosal resection are the “suck and cut” technique using a cap on the endoscope or a ligation device to create a pseudocroup of the carcinoma. Submucosal injection of saline or other solutions is recommended prior to diathermic mucosectomy in order to reduce the risk of perforation or haemorrhage. The long term results of endoscopic mucosal resection show tumor speci?c 5 year survival rates of about 97% especially if the indication is restricted to m1 and m2 mucosal carcinomas. 展开更多
关键词 endoscopic mucosal resection esophageal cancer Barrett’s esophagus ADENOCARCINOMA squa- mous cell carcinoma
下载PDF
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: A prospective study 被引量:14
3
作者 Corrado Pedrazzani Filippo Catalano +5 位作者 Mara Festini Germana Zerman Anna Tomezzoli Andrea Ruzzenente Alfredo Guglielmi Giovanni de Manzoni 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第12期1872-1875,共4页
AIM: This prospective study evaluated the effectiveness of 90 W argon plasma coagulation (APC) for the ablation of Barrett's esophagus (BE) that is considered to be the main risk factor for the development of esop... AIM: This prospective study evaluated the effectiveness of 90 W argon plasma coagulation (APC) for the ablation of Barrett's esophagus (BE) that is considered to be the main risk factor for the development of esophageal adenocarcinoma.METHODS: The results from 25 patients, observed at the First Department of General Surgery, University of Verona, Italy, from October 2000 to October 2003, who underwent APC for histologically proven BE were prospectively analyzed.RESULTS: The ablation treatment was completed in all the patients but one (96%). The mean number of APC sessions needed to complete ablation was 1.6 (total number: 40). The eradication was obtained in the majority of cases by one session only (60%), two sessions were required in 24% of the cases and three or more in 16%.About 43% of the sessions were complicated. Retrosternal pain (22.5%) and fever (17.5%) were the most frequent symptoms. Only one major complication occurred, it was an hemorrhage due to ulcer formation on the treated esophagus that required urgent endoscopic sclerosis and admission. The follow-up was accomplished in all the patients with a mean period of 26.3 mo and 20 patients (84%) with a follow-up period longer than 24 mo. Only one patient showed a relapse of metaplastic mucosa 12 mo after the completion of ablation. The patient was hence re-treated and now is free from recurrence 33 mo later.CONCLUSION: High power setting (90 W) APC showed to be safe and effective. The effects persist at a mean follow-up period of two years with a comparable cost in term of complications with respect to standard power settings. Further studies with greater number of patients are required to confirm these results and to assess if ablation reduces the incidence of malignant progression. 展开更多
关键词 Barrett's esophagus Argon plasma coagulation Endoscopic treatment
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部